Mangafodipir, IC and IP increased by 2.3-, 3.2- and 4.8-fold the caspase-3 activity (P<0.001, 0.01 and 0.01, respectively) versus the ischemia control group (Fig 5B). Here, CASP3 is linked to ischemia.